Dagmar Eigner, Dieter Scholz: Ayahuasca – Liane der Geister. In: Pharmazie in Unserer Zeit. 14, 1985, S. 65–76, doi:10.1002/pauz.19850140302.
Dennis J. McKenna, G.H.N. Towers, et al.: Monoamine oxidase inhibitors in South American hallucinogenic plants: Tryptamine and β-carboline constituents of Ayahuasca. In: Journal of Ethnopharmacology. 10, 1984, S. 195–223, doi:10.1016/0378-8741(84)90003-5.
E. H. McIlhenny, K. E. Pipkin, L. J. Standish, H. A. Wechkin, R. Strassman, S. A. Barker: Direct analysis of psychoactive tryptamine and harmala alkaloids in the Amazonian botanical medicine ayahuasca by liquid chromatography-electrospray ionization-tandem mass spectrometry. In: Journal of chromatography. A. Band 1216, Nummer 51, Dezember 2009, S. 8960–8968, ISSN1873-3778. doi:10.1016/j.chroma.2009.10.088. PMID 19926090.
Y. H. Wang, V. Samoylenko, B. L. Tekwani, I. A. Khan, L. S. Miller, N. D. Chaurasiya, M. M. Rahman, L. M. Tripathi, S. I. Khan, V. C. Joshi, F. T. Wigger, I. Muhammad: Composition, standardization and chemical profiling of Banisteriopsis caapi, a plant for the treatment of neurodegenerative disorders relevant to Parkinson’s disease. In: Journal of ethnopharmacology. Band 128, Nummer 3, April 2010, S. 662–671, ISSN1872-7573. doi:10.1016/j.jep.2010.02.013. PMID 20219660. PMC 2878139 (freier Volltext).
Robert S. Gable: Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids. In: Addiction. Band102, Nr.1. Society for the Study of Addiction, Januar 2007, ISSN1360-0443, S.24–34, doi:10.1111/j.1360-0443.2006.01652.x, PMID 17207120 (englisch).
J. Riba: Human Pharmacology of Ayahuasca: Subjective and Cardiovascular Effects, Monoamine Metabolite Excretion, and Pharmacokinetics. In: Journal of Pharmacology and Experimental Therapeutics. 306, 2003, S. 73, doi:10.1124/jpet.103.049882.
Paulo Cesar Ribeiro Barbosa, Joel Sales Giglio, Paulo Dalgalarrondo: Altered States of Consciousness and Short-Term Psychological After-Effects Induced by the First Time Ritual Use of Ayahuasca in an Urban Context in Brazil. In: Journal of Psychoactive Drugs. 37, 2005, S. 193, doi:10.1080/02791072.2005.10399801.
Rafael G. Dos Santos, José Carlos Bouso|, Jaime E. C. Hallak: Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies. In: Therapeutic Advances in Psychopharmacology, Band 7, Nr. 4, 1. April 2017, S. 141–157, doi:10.1177/2045125316689030, PMID 28540034, PMC 5433617 (freier Volltext)
R. G. dos Santos: A critical evaluation of reports associating ayahuasca with life-threatening adverse reactions. In: Journal of psychoactive drugs. Band 45, Nummer 2, 2013 Apr–Jun, S. 179–188, doi:10.1080/02791072.2013.785846, PMID 23909005 (Review).
José M. Capriles, Christine Moore, Juan Albarracin-Jordan, Melanie J. Miller: Chemical evidence for the use of multiple psychotropic plants in a 1,000-year-old ritual bundle from South America. In: Proceedings of the National Academy of Sciences. 1. Mai 2019, ISSN0027-8424, S.201902174, doi:10.1073/pnas.1902174116, PMID 31061128.
erowid.org
JPEG-Datei. In: erowid.org. Abgerufen am 22. März 2016.
google.com
Patent USPP5751P: Banisteriopsis caapi (cv) 'Da Vine'. Angemeldet am 7. November 1984, veröffentlicht am 17. Juni 1986, Erfinder: Loren S. Miller.
E. H. McIlhenny, K. E. Pipkin, L. J. Standish, H. A. Wechkin, R. Strassman, S. A. Barker: Direct analysis of psychoactive tryptamine and harmala alkaloids in the Amazonian botanical medicine ayahuasca by liquid chromatography-electrospray ionization-tandem mass spectrometry. In: Journal of chromatography. A. Band 1216, Nummer 51, Dezember 2009, S. 8960–8968, ISSN1873-3778. doi:10.1016/j.chroma.2009.10.088. PMID 19926090.
Y. H. Wang, V. Samoylenko, B. L. Tekwani, I. A. Khan, L. S. Miller, N. D. Chaurasiya, M. M. Rahman, L. M. Tripathi, S. I. Khan, V. C. Joshi, F. T. Wigger, I. Muhammad: Composition, standardization and chemical profiling of Banisteriopsis caapi, a plant for the treatment of neurodegenerative disorders relevant to Parkinson’s disease. In: Journal of ethnopharmacology. Band 128, Nummer 3, April 2010, S. 662–671, ISSN1872-7573. doi:10.1016/j.jep.2010.02.013. PMID 20219660. PMC 2878139 (freier Volltext).
Robert S. Gable: Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids. In: Addiction. Band102, Nr.1. Society for the Study of Addiction, Januar 2007, ISSN1360-0443, S.24–34, doi:10.1111/j.1360-0443.2006.01652.x, PMID 17207120 (englisch).
Rafael G. Dos Santos, José Carlos Bouso|, Jaime E. C. Hallak: Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies. In: Therapeutic Advances in Psychopharmacology, Band 7, Nr. 4, 1. April 2017, S. 141–157, doi:10.1177/2045125316689030, PMID 28540034, PMC 5433617 (freier Volltext)
R. G. dos Santos: A critical evaluation of reports associating ayahuasca with life-threatening adverse reactions. In: Journal of psychoactive drugs. Band 45, Nummer 2, 2013 Apr–Jun, S. 179–188, doi:10.1080/02791072.2013.785846, PMID 23909005 (Review).
José M. Capriles, Christine Moore, Juan Albarracin-Jordan, Melanie J. Miller: Chemical evidence for the use of multiple psychotropic plants in a 1,000-year-old ritual bundle from South America. In: Proceedings of the National Academy of Sciences. 1. Mai 2019, ISSN0027-8424, S.201902174, doi:10.1073/pnas.1902174116, PMID 31061128.
Pichini S, Marchei E, García-Algar O, Gomez A, Di Giovannandrea R, Pacifici R: Ultra-high-pressure liquid chromatography tandem mass spectrometry determination of hallucinogenic drugs in hair of psychedelic plants and mushrooms consumers., J Pharm Biomed Anal. 2014 Nov;100:284-289, PMID 25171488
Gambelunghe C, Aroni K, Rossi R, Moretti L, Bacci M: Identification of N,N-dimethyltryptamine and beta-carbolines in psychotropic ayahuasca beverage., Biomed Chromatogr. 2008 Oct;22(10):1056-9, PMID 18506697
Gaujac A, Dempster N, Navickiene S, Brandt SD, de Andrade JB: Determination of N,N-dimethyltryptamine in beverages consumed in religious practices by headspace solid-phase microextraction followed by gas chromatography ion trap mass spectrometry., Talanta. 2013 Mar 15;106:394-8, PMID 23598143
Beatriz Caiuby Labate, Kevin Feeney: Ayahuasca and the process of regulation in Brazil and internationally: Implications and challenges. In: International Journal of Drug Policy. Nr.23. Elsevier, 2012, ISSN0955-3959, S.154–161 (englisch, pdfs.semanticscholar.org [abgerufen am 26. August 2019]).pdfs.semanticscholar.org (Memento vom 7. März 2019 im Internet Archive)
Beatriz Caiuby Labate, Kevin Feeney: Ayahuasca and the process of regulation in Brazil and internationally: Implications and challenges. In: International Journal of Drug Policy. Nr.23. Elsevier, 2012, ISSN0955-3959, S.154–161 (englisch, pdfs.semanticscholar.org [abgerufen am 26. August 2019]).pdfs.semanticscholar.org (Memento vom 7. März 2019 im Internet Archive)
E. H. McIlhenny, K. E. Pipkin, L. J. Standish, H. A. Wechkin, R. Strassman, S. A. Barker: Direct analysis of psychoactive tryptamine and harmala alkaloids in the Amazonian botanical medicine ayahuasca by liquid chromatography-electrospray ionization-tandem mass spectrometry. In: Journal of chromatography. A. Band 1216, Nummer 51, Dezember 2009, S. 8960–8968, ISSN1873-3778. doi:10.1016/j.chroma.2009.10.088. PMID 19926090.
Y. H. Wang, V. Samoylenko, B. L. Tekwani, I. A. Khan, L. S. Miller, N. D. Chaurasiya, M. M. Rahman, L. M. Tripathi, S. I. Khan, V. C. Joshi, F. T. Wigger, I. Muhammad: Composition, standardization and chemical profiling of Banisteriopsis caapi, a plant for the treatment of neurodegenerative disorders relevant to Parkinson’s disease. In: Journal of ethnopharmacology. Band 128, Nummer 3, April 2010, S. 662–671, ISSN1872-7573. doi:10.1016/j.jep.2010.02.013. PMID 20219660. PMC 2878139 (freier Volltext).
Robert S. Gable: Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids. In: Addiction. Band102, Nr.1. Society for the Study of Addiction, Januar 2007, ISSN1360-0443, S.24–34, doi:10.1111/j.1360-0443.2006.01652.x, PMID 17207120 (englisch).
José M. Capriles, Christine Moore, Juan Albarracin-Jordan, Melanie J. Miller: Chemical evidence for the use of multiple psychotropic plants in a 1,000-year-old ritual bundle from South America. In: Proceedings of the National Academy of Sciences. 1. Mai 2019, ISSN0027-8424, S.201902174, doi:10.1073/pnas.1902174116, PMID 31061128.
Beatriz Caiuby Labate, Kevin Feeney: Ayahuasca and the process of regulation in Brazil and internationally: Implications and challenges. In: International Journal of Drug Policy. Nr.23. Elsevier, 2012, ISSN0955-3959, S.154–161 (englisch, pdfs.semanticscholar.org [abgerufen am 26. August 2019]).pdfs.semanticscholar.org (Memento vom 7. März 2019 im Internet Archive)
